E. Ozer Et Al. , "Infliximab alleviates the mortality, mesenteric hypoperfusion, aortic dysfunction, and multiple organ damage in septic rats.," Canadian journal of physiology and pharmacology , vol.95, pp.866-872, 2017
Ozer, E. Et Al. 2017. Infliximab alleviates the mortality, mesenteric hypoperfusion, aortic dysfunction, and multiple organ damage in septic rats.. Canadian journal of physiology and pharmacology , vol.95 , 866-872.
Ozer, E., Goktas, M., Kilinc, I., Toker, A., Bariskaner, H., Ugurluoglu, C., ... Iskit, A. B.(2017). Infliximab alleviates the mortality, mesenteric hypoperfusion, aortic dysfunction, and multiple organ damage in septic rats.. Canadian journal of physiology and pharmacology , vol.95, 866-872.
Ozer, EK Et Al. "Infliximab alleviates the mortality, mesenteric hypoperfusion, aortic dysfunction, and multiple organ damage in septic rats.," Canadian journal of physiology and pharmacology , vol.95, 866-872, 2017
Ozer, EK Et Al. "Infliximab alleviates the mortality, mesenteric hypoperfusion, aortic dysfunction, and multiple organ damage in septic rats.." Canadian journal of physiology and pharmacology , vol.95, pp.866-872, 2017
Ozer, E. Et Al. (2017) . "Infliximab alleviates the mortality, mesenteric hypoperfusion, aortic dysfunction, and multiple organ damage in septic rats.." Canadian journal of physiology and pharmacology , vol.95, pp.866-872.
@article{article, author={EK Ozer Et Al. }, title={Infliximab alleviates the mortality, mesenteric hypoperfusion, aortic dysfunction, and multiple organ damage in septic rats.}, journal={Canadian journal of physiology and pharmacology}, year=2017, pages={866-872} }